Advertisement

Search Results

Advertisement



Your search for Catherine C. Coombs, MD, and Anthony R. Mato, MD, MSCE matches 1 pages

Showing 1 - 1


hematologic malignancies
leukemia

Duvelisib in Resistant Chronic Lymphocytic Leukemia: Expanding the Treatment Armamentarium

The phase III DUO trial, reported by Flinn et al and reviewed in this issue of The ASCO Post, has led to the U.S. Food and Drug Administration (FDA) approval of a novel B-cell receptor (BCR) kinase inhibitor, duvelisib (Copiktra), which targets phosphoinositide 3-kinase (PI3K)-δ/γ in patients...

Advertisement

Advertisement



;
Advertisement